Annual Meeting: March 19 – 23, 2023
ToxExpo: March 20 – 22, 2023
Nashville Music City Center, Nashville, TN
CNS drug discovery with translatable neuroscience technology
High attrition rates in CNS clinical trials is an indication that current testing is failing to predict safety/efficacy of compounds. NeuCyte supports early phases of drug discovery programs as well as the investigation of MOAs for experimental compounds. Based on the SynFire® technology, our human neural in vitro platforms are uniquely suited for assessing relevant higher order electrophysiology readouts, which allow for a better predictor of drug efficacy and potential CNS safety/toxicology.
Society of Toxicology
11190 Sunrise Valley Dr, Ste 300
Reston, VA 20191
Music City Center
Nashville, TN 37203
Boost your presence?
Society of Toxicology. All rights reserved.